Author

Yvonne M.R. Adema

Observed names: Y.M.R. Adema, Yvonne M R Adema, Yvonne M. R. Adema

Observed institutions: University Medical Center Groningen, University of Groningen

OpenAlex ID: A5073692908

Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial

2022 · Marcia M L Kho, A Lianne Messchendorp, et al. · The Lancet Infectious Diseases · 72

Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant

2022 · Jan-Stephan F Sanders, A Lianne Messchendorp, et al. · Clinical Infectious Diseases · 51

The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients

2023 · S. Reshwan K. Malahe, Yvette den Hartog, et al. · American Journal of Transplantation · 12

Replacing Mycophenolate Mofetil by Everolimus in Kidney Transplant Recipients to Increase Vaccine Immunogenicity: Results of a Randomized Controlled Trial

2025 · A Lianne Messchendorp, Luca M Zaeck, et al. · Clinical Infectious Diseases · 5

Adherence to preventive measures after SARS-CoV-2 vaccination and after awareness of antibody response in kidney transplant recipients in the Netherlands: a nationwide questionnaire study

2023 · Sophie C. Frölke, Pim Bouwmans, et al. · EClinicalMedicine · 5

Revealing the significance of IL-2 and IL-5 in SARS-CoV-2-specific T-cell responses in kidney transplant recipients

2024 · Yvette den Hartog, S. Reshwan K. Malahe, et al. · npj Viruses · 2

Works count: 6

Citation count: 147

H-index: 5

I10-index: 3